GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
120.19
+1.93 (1.63%)
At close: Oct 6, 2025, 4:00 PM EDT
120.15
-0.04 (-0.03%)
After-hours: Oct 6, 2025, 7:21 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $3.45 billion as of October 6, 2025. Its market cap has increased by 215.32% in one year.
Market Cap
3.45B
Enterprise Value
3.43B
1-Year Change
215.32%
Ranking
Category
Stock Price
$120.19
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.45B, a decrease of -80.71%. That is a compound annual growth rate of -28.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 3.45B | 63.52% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
| Nov 4, 2020 | 17.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |